An International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer
Jessica A. Zerillo(Beth Israel Deaconess Medical Center), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), John Zalcberg(Peter MacCallum Cancer Centre), Donna Bauer(Cancer Australia), Pamela K. McAllister(American Society of Clinical Oncology), A.C.M. van Bommel(Leiden University Medical Center), Veena Shankaran(Seattle Cancer Care Alliance), Ann M. Berger(University of Maryland, Baltimore), Muhammad Radzi Abu Hassan(Hospital Sultanah Bahiyah), Corinna Langelotz(Charité - Universitätsmedizin Berlin), Josep M. Borràs(Escola Superior de Música de Catalunya), Caleb Stowell, Eino B. van Duyn(Medisch Spectrum Twente), Jacob Lippa, G. Boland(Harvard University), Mary K. Buss(Beth Israel Deaconess Medical Center), Joanne Ngeow(Nanyang Technological University), Robert R. Cima(Mayo Clinic in Arizona), Harvey J. Mamon(Brigham and Women's Hospital), John D. Lloyd(Breast Cancer Alliance), Bruce D. Minsky(The University of Texas MD Anderson Cancer Center), A. Craig Lynch(Peter MacCallum Cancer Centre), Eric Van Cutsem(KU Leuven), Kim Ryan(Cancer Support Community), Melissa P. Upton(Beth Israel Deaconess Medical Center), Maartje G. Schouwenburg(Leiden University Medical Center), Samuel R.G. Finlayson(Dartmouth–Hitchcock Medical Center), Cornelis JH van de Velde(Leiden University), Skye Hung‐Chun Cheng(Koo Foundation Sun Yat-Sen Cancer Center)
Cited by 134
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
|Journal of Clinical Investigation|2017|3.9k
<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
|New England Journal of Medicine|2008|3.6k
Phase 3 Trial of <sup>177</sup> Lu-Dotatate for Midgut Neuroendocrine Tumors
|New England Journal of Medicine|2017|3.2k